Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL
International Society of Paediatric Surgical Oncology (IPSO) surgical practice guidelines
PET scanning in patients with classical Hodgkin lymphoma outside of Europe and North America
Pandemic strategising for cancer hospital stockpiles
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Cancer care in Turkey: Paediatric oncology during COVID-19 and palliative care
Update on the new EUSOMA quality indicators for breast cancer
The optimal approach after neoadjuvant treatment: The Lucerne toolbox
Lung cancer in India
The global impact of the FDA's changing approval standards
ecancer-AORTIC special issue on cancer research training in Africa
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO